Clinical Trials Directory

Trials / Unknown

UnknownNCT03195023

Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

Effect of Renin-angiotensin-system (RAS) Blocker Drugs on Chronic Kidney Disease (CKD) Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
106 (estimated)
Sponsor
Hospital General Universitario Gregorio Marañon · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effect of renin-angiotensin blockers on chronic kidney disease progression in elderly (\>65 years old) patients with non-proteinuric nephropathies. Half of the patients will receive angiotensin converting enzyme inhibitors, while the other half will not receive them. Renal function, proteinuria and cardiovascular events will be follow up during a three year period.

Detailed description

STUDY DESIGN: Open, multicentre, prospective, parallel-group, randomized controlled study comparing the effect of an angiotensin converting enzyme inhibitor (ACEI) vs standard antihypertensive treatment without ACEI, in the progression of renal disease in elderly patients with non-proteinuric 3-4 stage chronic renal disease. Elderly patients (\> 65 years) with moderate-severe non-proteinuric chronic renal disease (estimated Glomerular Filtrate Rate between 19-59 ml per minute per 1.73 m2 using the Chronic Kidney Disease Epidemiology Collaboration Group equation) and urine-creatinine rate \< 30 mg/g, will be included. They will be randomly assigned in a 1:1 ratio to receive ACEI or standard antihypertensive treatment. Patients will be followed up for 3 years.

Conditions

Interventions

TypeNameDescription
DRUGLisinopril
DRUGAmlodipinePatients in this arm will receive antihypertensive treatment different from RAS blockers. If they previously received RAS blockers, they will be substitute for either Amlodipine or Lercanidipine +/- diuretics

Timeline

Start date
2015-06-01
Primary completion
2019-12-01
Completion
2022-12-01
First posted
2017-06-22
Last updated
2019-02-22

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03195023. Inclusion in this directory is not an endorsement.